Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data

Hu, Zhuozheng; Wu, Jiajun; Zhou, Weijun; Wang, Kang; Zhang, Wenxiong

doi:10.7150/jca.94501



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2024; 15(12):3766-3780. doi:10.7150/jca.94501 This issue Cite

Research Paper

Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data

Zhuozheng Hu, MD¹, Jiajun Wu, MD¹, Weijun Zhou, MD¹, Kang Wang^2✉, Wenxiong Zhang, MD^1✉

1. Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
2. Department of Traditional Chinese Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.

Citation:

Hu Z, Wu J, Zhou W, Wang K, Zhang W. Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data. J Cancer 2024; 15(12):3766-3780. doi:10.7150/jca.94501. https://www.jcancer.org/v15p3766.htm

Other styles

Abstract

Background: The role of endothelial cells in tumor progression is considerable, yet the effect of endothelial cell immune-related genes (EIRGs) is still unclear. This research aimed to scrutinize the prognostic value of EIRGs in lung adenocarcinoma (LUAD) and provide further insights into the abovementioned uncertainties.

Methods: After single-cell RNA sequencing (scRNA-seq) samples were obtained from the Gene Expression Omnibus (GEO) database, they were integrated with bulk RNA sequencing data from The Cancer Genome Atlas (TCGA). Prognostic markers were determined and a prognostic model was developed. From this model, a nomogram was constructed. We analyzed the biological mechanism of the EIRGs in LUAD, including functional enrichment, tumor mutational burden (TMB), tumor microenvironment (TME) analyses and drug sensitivity. We validated the signature by validating the external cohort GSE31210 and RT-qPCR.

Results: After analyzing the model constructed from eight EIRGs, we observed that high-risk group (HG) LUAD patients (a risk score exceeding 4.65) exhibited unfavorable outcomes according to Kaplan‒Meier survival curves. This outcome was confirmed by GSE31210. The nomogram based on the model demonstrated significant predictive value. HG was influenced primarily by steroid hormone biosynthesis and ECM receptor interactions. The TMB in HGs was greater than that in the LG. Analysis of drug sensitivity revealed the direction for individualized treatment for both risk cohorts. Variations in the expression of EIRGs have been confirmed via RT-qPCR in several LUAD cell lines.

Conclusions: The prognostic model and nomogram above are valuable for determining the survival rate and treatment options for LUAD patients.

Keywords: Endothelial cell, Immune-related genes, Lung adenocarcinoma, Prognosis Signature, Single-Cell, Bulk RNA-Sequencing

Citation styles

APA

Hu, Z., Wu, J., Zhou, W., Wang, K., Zhang, W. (2024). Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data. Journal of Cancer, 15(12), 3766-3780. https://doi.org/10.7150/jca.94501.

ACS

Hu, Z.; Wu, J.; Zhou, W.; Wang, K.; Zhang, W. Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data. J. Cancer 2024, 15 (12), 3766-3780. DOI: 10.7150/jca.94501.

NLM

CSE

Hu Z, Wu J, Zhou W, Wang K, Zhang W. 2024. Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data. J Cancer. 15(12):3766-3780.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.